Definition: Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).
note category; HIV SERONEGATIVITY (Cat G) is also available; /diag /immunol permitted but use caution; coord IM with HIV-1 /immunol (IM) or HIV-2 /immunol (IM); do not confuse with HIV SEROPREVALENCE, an epidemiol concept; DF: HIV SEROPOS
See AlsoHIV Seronegativity; HIV Seroprevalence
Other names HTLV-III Seropositivity; HTLV-III Seroconversion; HIV Seroconversion; HIV Antibody Positivity; Anti-HIV Positivity; AIDS Seropositivity; AIDS Seroconversion; Seropositivity, HTLV-III; Seropositivity, HIV; Seropositivity, AIDS; Seropositivities, HTLV-III; Seropositivities, HIV; Seropositivities, AIDS; Seroconversions, HTLV-III; Seroconversions, HIV; Seroconversions, AIDS; Seroconversion, HTLV-III; Seroconversion, HIV; Seroconversion, AIDS; Positivity, HIV Antibody
